GlassScriptPhysician profile
Mary-Jo Obeid
NPI 1730742735
$1,299.52
in general payments reported to CMS, 2019-2025
5 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $98.64 · 2024: $892 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.27 |
| Education | $159.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $972.64 | 2024-2025 | Versacross Access Solution, Farapulse, Watchman Flx |
| Medtronic, INC. | $159.25 | 2024 | Adapta |
| Merck Sharp & Dohme LLC | $98.64 | 2023 | Verquvo |
| Biosense Webster, INC. | $39.34 | 2024 | Carto 3 |
| Abbott Laboratories | $29.65 | 2024 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary-Jo Obeid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.